|12 Months Ended|
Dec. 31, 2022
NOTE 21 - SUBSEQUENT EVENTS
As of March 30, 2023 the Company issued an aggregate of 18,782 shares of its common stock for consulting services and one promissory note valued at $29,703.
As of March 30, 2023, the Company entered into a $50,000 unsecured promissory note.
On January 20, 2023, the board of directors of BioCorRx Inc. appointed Mr. Harsha Murthy as a member of the Board.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef